Skip to main content
. 2023 Jul 10;13:11105. doi: 10.1038/s41598-023-37702-z

Figure 2.

Figure 2

1 µM of SR144528 reduces LPS/IFN-γ-induced microglial inflammatory cytokine secretion independent of the CB2 receptor. (A) Experimental setup. Primary microglia of WT and CB2-/- mice were pre-treated with 1 µM SR144528 for 15 min, followed by LPS/IFN-γ stimulation for 16 h. (BD) Levels of cytokines/ chemokines were quantified in supernatants using ELISA. (B) TNF-α, (C) IL-6, and (D) CCL2. N = 4–5 samples/genotype/stimulation (representative data from two independent microglia preparations). Data are presented as mean ± SD. Two-way ANOVA followed by Tukey's multiple comparisons. #### p < 0.0001, ## p < 0.01, # p < 0.05 indicate significance to the untreated control group. Significant differences between LPS/IFN-γ vs. LPS/IFN-γ pre-treated with SR144528 are indicated with *** p < 0.001, ** p < 0.01, * p < 0.05.